Clinical Trial Update: Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 pragmatic trial evaluating amiodarone to reduce postoperative atrial fibrillation in patients undergoing cardiac surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Surgery, Cardiac, Atrial Fibrillation | Phase 4 | Status: WITHDRAWN